Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Product Developments
DXCM logo

DexCom Generates $1.44 Billion in Operating Cash Flow Amid Global Expansion

DXCM10-KFiling Date: 2/12/2026
DexCom, Inc.
Description

What this story covers

DexCom's 2025 10-K shows explosive growth from G7 and Stelo sensors. Despite FDA warnings and Medicare pricing pressures, the company holds $2 billion liquidity and market dominance.

Story snapshot

CompanyDexCom, Inc.
TickerDXCM
VariantStandard detailed
Duration11:35
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001093557-26-000027
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in